Endocarditis (Streptococcus gallolyticus - S. bovis)

Overview


Plain-Language Overview

Endocarditis caused by Streptococcus gallolyticus (formerly S. bovis) is an infection of the heart's inner lining, particularly affecting the heart valves. This condition involves the growth of bacterial colonies on the valves, which can interfere with normal heart function. It primarily affects the cardiovascular system and can lead to serious complications like heart failure or stroke if untreated. The infection often develops slowly and may cause symptoms such as fever, fatigue, and heart murmurs. Because this bacterium is linked to colorectal cancer, patients diagnosed with this type of endocarditis often require further evaluation for underlying gastrointestinal disease.

Clinical Definition

Endocarditis due to Streptococcus gallolyticus is a form of infective endocarditis characterized by colonization and infection of the heart valves or endocardial surface by this specific gram-positive cocci. It typically arises from bacteremia originating in the gastrointestinal tract, often associated with colorectal neoplasms or mucosal lesions. The pathogenesis involves bacterial adherence to damaged or abnormal heart valves, leading to formation of vegetations composed of bacteria, fibrin, and inflammatory cells. Clinically, it presents with fever, new or changing heart murmurs, and embolic phenomena. This infection is significant due to its association with colorectal cancer screening and the potential for systemic embolization and valvular destruction.

Inciting Event

  • Transient bacteremia from gastrointestinal mucosal disruption, often due to colorectal lesions or procedures.

  • Colonoscopy or colorectal surgery can precipitate bacteremia with S. gallolyticus.

  • Dental procedures or poor oral hygiene may occasionally trigger bacteremia in susceptible individuals.

Latency Period

  • Days to weeks from bacteremia onset to development of clinical endocarditis symptoms.

  • Subacute progression is typical, with symptoms evolving over 1 to 4 weeks before diagnosis.

Diagnostic Delay

  • Nonspecific symptoms such as fatigue and low-grade fever lead to delayed suspicion of endocarditis.

  • Lack of early blood cultures or failure to recognize S. gallolyticus as a pathogen delays diagnosis.

  • Attribution of symptoms to other chronic illnesses or malignancy-related causes can obscure diagnosis.

Clinical Presentation


Signs & Symptoms

  • Fever and chills as the most common presenting symptoms

  • Fatigue and malaise due to chronic infection

  • Night sweats reflecting systemic inflammation

  • New or worsening heart murmur indicating valvular involvement

  • Embolic phenomena such as stroke or limb ischemia from septic emboli

History of Present Illness

  • Subacute onset of fever, malaise, and night sweats over several weeks is common.

  • New or changing heart murmur often develops as vegetations damage valves.

  • Symptoms of embolic phenomena such as stroke or splenic infarcts may appear.

  • Gastrointestinal symptoms may be present if underlying colorectal pathology exists.

Past Medical History

  • Known valvular heart disease or prior endocarditis increases risk and influences presentation.

  • History of colorectal cancer or polyps is frequently associated with S. gallolyticus infection.

  • Recent invasive procedures including colonoscopy or dental work may precede symptom onset.

Family History

  • There are no well-established familial syndromes directly linked to S. gallolyticus endocarditis.

  • Family history of colorectal cancer may be relevant due to the association with S. gallolyticus bacteremia.

Physical Exam Findings

  • New or changing heart murmur, often a regurgitant murmur due to valvular damage

  • Splinter hemorrhages under the fingernails indicating microvascular emboli

  • Janeway lesions, painless erythematous macules on palms and soles from septic emboli

  • Osler nodes, tender subcutaneous nodules on fingers or toes from immune complex deposition

  • Petechiae on conjunctiva or skin reflecting microvascular injury

Diagnostic Workup


Diagnostic Criteria

Diagnosis relies on the Duke criteria, which include positive blood cultures for Streptococcus gallolyticus and evidence of endocardial involvement on echocardiography. Key findings include persistent bacteremia with this organism and visualization of vegetations or new valvular regurgitation. Additional supportive criteria include vascular phenomena and immunologic signs. Confirmatory diagnosis requires integration of clinical, microbiological, and imaging data.

Pathophysiology


Key Mechanisms

  • Bacteremia with Streptococcus gallolyticus leads to colonization of damaged or abnormal cardiac valves.

  • Formation of vegetations composed of bacteria, fibrin, and platelets on the endocardial surface causes local tissue destruction.

  • Immune complex deposition and systemic inflammation contribute to vascular phenomena and embolic complications.

  • Biofilm formation by S. gallolyticus enhances bacterial persistence and resistance to host defenses and antibiotics.

InvolvementDetails
Organs

Heart is the central organ involved, with infection primarily affecting the cardiac valves causing endocarditis.

Colon is clinically relevant due to the association of Streptococcus gallolyticus bacteremia with colorectal cancer.

Kidneys may be affected by immune complex deposition causing glomerulonephritis as a complication.

Tissues

Endocardium is the primary tissue affected, where bacterial colonization and vegetation formation occur.

Valvular tissue undergoes destruction and fibrosis leading to valvular insufficiency or stenosis.

Cells

Neutrophils mediate acute inflammatory response and bacterial clearance in infected heart valves.

Macrophages participate in phagocytosis and antigen presentation during endocardial infection.

Endothelial cells line heart valves and become damaged, facilitating bacterial adherence and vegetation formation.

Chemical Mediators

C-reactive protein (CRP) is elevated as an acute phase reactant indicating systemic inflammation.

Interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α) promote local inflammation and fever in infective endocarditis.

Fibrinogen contributes to vegetation matrix formation by promoting fibrin deposition on damaged endothelium.

Treatments


Pharmacological Treatments

  • Penicillin G

    • Mechanism:
      • Inhibits bacterial cell wall synthesis by binding penicillin-binding proteins

    • Side effects:
      • Hypersensitivity reactions

      • Nephrotoxicity

      • Neurotoxicity

    • Clinical role:
      • First-line

  • Gentamicin

    • Mechanism:
      • Binds 30S ribosomal subunit causing misreading of mRNA and inhibiting protein synthesis

    • Side effects:
      • Nephrotoxicity

      • Ototoxicity

      • Neuromuscular blockade

    • Clinical role:
      • Adjunctive

  • Vancomycin

    • Mechanism:
      • Inhibits bacterial cell wall synthesis by binding D-Ala-D-Ala terminus of cell wall precursors

    • Side effects:
      • Nephrotoxicity

      • Red man syndrome

      • Ototoxicity

    • Clinical role:
      • Second-line

Non-pharmacological Treatments

  • Surgical valve repair or replacement is indicated in cases of heart failure, uncontrolled infection, or large vegetations.

  • Regular monitoring with echocardiography to assess valve function and detect complications.

  • Screening colonoscopy is recommended due to the association of Streptococcus gallolyticus with colorectal neoplasia.

Prevention


Pharmacological Prevention

  • Prophylactic antibiotics before dental or gastrointestinal procedures in high-risk patients

  • Early and appropriate intravenous antibiotic therapy targeting S. gallolyticus to prevent complications

Non-pharmacological Prevention

  • Regular dental hygiene and care to reduce bacteremia risk

  • Screening colonoscopy in patients diagnosed with S. gallolyticus endocarditis to detect colorectal neoplasia

  • Management of predisposing valvular heart disease to reduce turbulent flow and vegetation risk

  • Avoidance of intravenous drug use to prevent bacteremia

Outcome & Complications


Complications

  • Heart failure due to valvular destruction and regurgitation

  • Systemic embolization causing stroke, splenic infarcts, or renal infarcts

  • Perivalvular abscess formation leading to conduction abnormalities

  • Septic shock from uncontrolled bacteremia

  • Glomerulonephritis from immune complex deposition

Short-term Sequelae Long-term Sequelae
  • Persistent bacteremia despite antibiotic therapy

  • Acute valvular insufficiency causing hemodynamic instability

  • Septic emboli causing infarcts or abscesses in distant organs

  • Conduction abnormalities from perivalvular extension

  • Chronic valvular dysfunction requiring surgical valve repair or replacement

  • Recurrent endocarditis especially if underlying risk factors persist

  • Chronic heart failure from progressive valve damage

  • Increased risk of colorectal cancer necessitating ongoing surveillance

Differential Diagnoses


Endocarditis (Streptococcus gallolyticus - S. bovis) versus Infective Endocarditis due to Staphylococcus aureus

Endocarditis (Streptococcus gallolyticus - S. bovis)

Infective Endocarditis due to Staphylococcus aureus

Gram-positive cocci in chains, associated with subacute infection and gastrointestinal malignancy

Gram-positive cocci in clusters, often causing acute aggressive infection

Usually presents with subacute, indolent symptoms

Typically presents with acute, rapidly progressive symptoms

Commonly linked to underlying colorectal neoplasia or chronic liver disease

Often associated with intravenous drug use or healthcare exposure

Endocarditis (Streptococcus gallolyticus - S. bovis) versus Infective Endocarditis due to Enterococcus species

Endocarditis (Streptococcus gallolyticus - S. bovis)

Infective Endocarditis due to Enterococcus species

Gram-positive cocci in chains, sensitive to penicillin and associated with colon pathology

Gram-positive cocci in pairs and short chains, often resistant to many antibiotics

Strongly associated with colorectal cancer or adenomas

Frequently follows genitourinary or gastrointestinal procedures

Usually responds well to beta-lactam antibiotics alone

Often requires combination antibiotic therapy due to resistance

Endocarditis (Streptococcus gallolyticus - S. bovis) versus Nonbacterial Thrombotic Endocarditis (NBTE)

Endocarditis (Streptococcus gallolyticus - S. bovis)

Nonbacterial Thrombotic Endocarditis (NBTE)

Vegetations containing bacteria, confirmed by positive blood cultures

Sterile vegetations composed of fibrin and platelets without microorganisms

Presents with systemic infection signs and positive blood cultures

Often associated with malignancy or hypercoagulable states, presenting with embolic phenomena without infection signs

Positive blood cultures for Streptococcus gallolyticus

Negative blood cultures despite vegetations on echocardiogram

Endocarditis (Streptococcus gallolyticus - S. bovis) versus Infective Endocarditis due to HACEK organisms

Endocarditis (Streptococcus gallolyticus - S. bovis)

Infective Endocarditis due to HACEK organisms

Gram-positive cocci in chains, easily cultured on standard media

Fastidious Gram-negative bacteria requiring special culture conditions

Subacute course with positive blood cultures

Subacute course with culture-negative endocarditis common

Blood cultures positive within standard incubation period

Blood cultures often delayed or negative due to slow growth

Endocarditis (Streptococcus gallolyticus - S. bovis) versus Rheumatic Heart Disease with Secondary Endocarditis

Endocarditis (Streptococcus gallolyticus - S. bovis)

Rheumatic Heart Disease with Secondary Endocarditis

Vegetations often on the aortic or mitral valve without prior rheumatic changes

Chronic valvular damage with vegetations typically on the mitral valve

Typically affects older adults with colorectal pathology

Usually affects children and young adults in endemic areas

No history of rheumatic fever; associated with gastrointestinal malignancy

History of untreated streptococcal pharyngitis or rheumatic fever

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.